Skip to content
healthcare.dev
Get a free key

grisofulvin

NDC 69097-361, grisofulvin, suspension, from Cipla USA Inc..

Product NDC
69097-361
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA065354
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-361 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GRISEOFULVIN125 mg/5mL

Pharmacologic classes

Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]

Package NDCNDC-11Package
69097-361-0869097036108120 mL in 1 BOTTLE (69097-361-08)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d5c737e5-51b8-4322-a2a5-4d4a392c1f56

  • NADAC price for package 69097036108

    GET /v1/drugs/nadac/69097036108

Use it

Look up 69097-361 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-361 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-361. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.